T1	Treatment 7 55	granulocyte-macrophage colony-stimulating factor
T2	Treatment 60 74	erythropoietin
T3	Treatment 96 130	autologous marrow transplantation.
T4	Treatment 175 313	combination of recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) and recombinant human erythropoietin (rHuEPO)
T5	Treatment 326 340	autologous BMT
T6	Treatment 443 529	six concurrent control and 65 historical control patients treated with rhGM-CSF alone.
